Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices

Demonstrating mood repair with a situation-based measure of self-compassion and self-criticism

(2015) Caroline J. Falconer et al.   PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE

Embodying Compassion: A Virtual Reality Paradigm for Overcoming Excessive Self-Criticism

(2014) Caroline J. Falconer et al.   PLoS One

Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

(2013) Andrew C. Parrott   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users

(2013) Celia JA Morgan et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Schedule I drug laws on neuroscience research and treatment innovation

(2013) David J. Nutt et al.   NATURE REVIEWS NEUROSCIENCE

Oxytocinergic regulation of endogenous as well as drug-induced mood

(2013) J.H. Broadbear et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators

(2013) Perla Kaliman et al.   PSYCHONEUROENDOCRINOLOGY

Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’

(2012) Tom P. Freeman et al.   ADDICTION

Antidepressant‐like effects of ecstasy in subjects with a predisposition to depression

(2012) Irina Majumder et al.   ADDICTIVE BEHAVIORS

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

(2012) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

An exploration of group compassion-focused therapy for personality disorder

(2012) Katherine M. Lucre et al.   PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE

Modulating social behavior with oxytocin: How does it work? What does it mean?

(2011) Patricia S. Churchland et al.   HORMONES AND BEHAVIOR

Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users

(2011) Tibor M. Brunt et al.   PSYCHOPHARMACOLOGY

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Empathy and Pro-Social Behavior in Rats

(2011) I. B.-A. Bartal et al.   SCIENCE

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

(2010) Gillinder Bedi et al.   BIOLOGICAL PSYCHIATRY

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Fears of compassion: Development of three self-report measures

(2010) Paul Gilbert et al.   PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE

Effects of MDMA on sociability and neural response to social threat and social reward

(2009) Gillinder Bedi et al.   PSYCHOPHARMACOLOGY

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

(2009) G. J. H. Dumont et al.   Social Neuroscience

Regulation of the Neural Circuitry of Emotion by Compassion Meditation: Effects of Meditative Expertise

(2008) Antoine Lutz et al.   PLoS One